GLP-1 receptor agonists: a magic bullet for obesity?

被引：0
|
作者：
不详
机构：
来源：
LANCET REGIONAL HEALTH-WESTERN PACIFIC | 2024年 / 51卷
关键词：
D O I：
10.1016/j.lanwpc.2024.101233
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Novel GLP-1 receptor agonists for diabetes
    Garber, Alan J.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (01) : 45 - 57
  • [42] Cardiovascular safety and GLP-1 receptor agonists
    Carty, David M.
    Drummond, Russell
    Fisher, Miles
    PRACTICAL DIABETES, 2013, 30 (06) : 242 - 245
  • [43] Variable Responses to GLP-1 Receptor Agonists
    Kunwar, Sandeep
    Samson, Kaeli
    Davis, Clifton
    Shivaswamy, Vijay
    Desouza, Cyrus
    DIABETES, 2022, 71
  • [44] GLP-1 Receptor Agonists and Kidney Protection
    Greco, Eulalia Valentina
    Russo, Giuseppina
    Giandalia, Annalisa
    Viazzi, Francesca
    Pontremoli, Roberto
    De Cosmo, Salvatore
    MEDICINA-LITHUANIA, 2019, 55 (06):
  • [45] GLP-1 receptor agonists and cardiovascular safety
    Huang, Yu-Yao
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S20 - S20
  • [46] The Cautious Promise of GLP-1 Receptor Agonists
    Dauterive, Rachel S.
    OCHSNER JOURNAL, 2024, 24 (03): : 165 - 166
  • [47] GLP-1 and dual GIP/GLP-1 receptor agonists increase risk of aspiration
    Reactions Weekly, 2025, 2044 (1) : 3 - 3
  • [48] Are GLP-1 agonists the answer to our obesity epidemic?
    Dapre, Elizabeth
    BRITISH JOURNAL OF GENERAL PRACTICE, 2023, 73 (733): : 365 - 365
  • [49] Therapy of obesity with GLP-1 agonists and limitations of the therapy
    Ludvik, Bernhard
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2025, 23
  • [50] Management of type 2 diabetes, obesity, or nonalcoholic steatohepatitis with high-dose GLP-1 receptor agonists and GLP-1 receptor-based co-agonists
    Goldenberg, Ronald M.
    Gilbert, Jeremy D.
    Manjoo, Priya
    Pedersen, Sue D.
    Woo, Vincent C.
    Lovshin, Julie A.
    OBESITY REVIEWS, 2024, 25 (03)
12345